Stereotaxis (STXS) Liabilities and Shareholders Equity (2010 - 2026)

Stereotaxis' (STXS) quarterly Liabilities and Shareholders Equity came in at $54.0 million in Q1 2026, up 18.21% year-on-year from $45.7 million in Q1 2025, and up 3.4% on a QoQ basis from $52.3 million in Q4 2025.

Stereotaxis (STXS) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $54.0 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 18.21% year-over-year to $54.0 million in Q1 2026; TTM through Mar 2026 was $193.0 million, a 7.62% increase from a year earlier, with the FY2025 full-year figure at $52.3 million, up 11.83% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $54.0 million, up from $52.3 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for STXS reached as high as $57.4 million in Q1 2022 and fell as low as $36.0 million in Q2 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $48.3 million across 5 years, with a median of $48.3 million in 2023.
  • Across the five-year window, Liabilities and Shareholders Equity decreased 25.46% in 2024 and grew 18.21% in 2026, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $53.4 million in 2022, then declined by 21.54% to $41.9 million in 2023, then rose by 11.49% to $46.7 million in 2024, then advanced by 11.83% to $52.3 million in 2025, then increased by 3.4% to $54.0 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $54.0 million in Q1 2026, $52.3 million in Q4 2025, and $45.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 31.62 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 20.88 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 50.83 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 39.01 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 8.78 Bn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 4.08 Bn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 12.48 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 14.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 6.31 Bn
10 Stereotaxis 136.49 Mn 121.87 Mn 3.79 Mn 54.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 54.03 Mn
Dec 31, 2025 52.25 Mn
Sep 30, 2025 45.59 Mn
Jun 30, 2025 41.17 Mn
Mar 31, 2025 45.71 Mn
Dec 31, 2024 46.72 Mn
Sep 30, 2024 50.94 Mn
Jun 30, 2024 36.01 Mn
Mar 31, 2024 39.45 Mn
Dec 31, 2023 41.91 Mn
Sep 30, 2023 44.53 Mn
Jun 30, 2023 48.32 Mn
Mar 31, 2023 50.71 Mn
Dec 31, 2022 53.41 Mn
Sep 30, 2022 56.08 Mn
Jun 30, 2022 56.68 Mn
Mar 31, 2022 57.43 Mn
Dec 31, 2021 60.99 Mn
Sep 30, 2021 61.92 Mn
Jun 30, 2021 57.34 Mn